Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BUY ALERT !(((((OCRX ((( TIME TO BUY -I JUST GET 20000 shares -
BUY ALERT-(((( HLTH ((((( Get Reach =This is real $$$$$ I just get 20000 shares for my kids . WOW!
I do believe this is time to sell and buy af//Good luck to all.
Why Sell today =because a future news will be when 3Q be realised at November till then price will drastically will go down / But you can kip it =it is your money – Good Luck to all –
it is only my opinion on this stock taking the past news and the fact this stock went down in 24 hours after good news 6-7 April.
I did sold all my holding at $1.495 will buy when it go to $0.79 in a three weeks.
I do believe this is time to sell and buy after 6 month =SELL -but you do what ever better for you it is your money//Good luck to all.
$ARGS =STRONG BUY WE SEE $1+ONLY GOING UP
Alert! Whisper on the streets that Teva Pharmaceuticals (Israel-US) negotiating with ARGS cancer drag joint development level 3 = the requiring 43% shares and rights for $1.82 What are you think about -please reply
I just buy in this price I need more -Good luck to all.
(PLUG) I just sold all shares Good luck to all
$ARGS =STRONG BUY WE SEE $1+ONLY GOING UP= AFTER JUDGE REJECTED DAMAGE CLAM IT IS SAME IF YOU LOST IN COSINO-YOU LIKE MONEY BACK
(PLUG) $3 raises target price Cowen and Company raises t from $1.75; outperform
https://wwwx3.royalbank.com/rbc/investing/quotes/companyNews.asp?docKey=356-L3N1HE2DW-1&sourceID=RTRIDS&headline=U.S.%20RESEARCH%20ROUNDUP-Aercap%20Holdings%2C%20Air%20Lease%2C%20Sabre&docDate=2017-04-06%2012:24:19&symbol=PLUG&country=US
Correction- PLUG HOT =inside News that pointing out the price of sell a warrants to Amazon will be calculated on 30 days trading starting April 5. 2017 till May 5. 2017 –which min that management of the PLUG must get more news so shares PLUG be more expensive then priced first time as IPO at $15.00 dollars a share.
For this second tranche as described above, the exercise price will be reset to 90% of the 30-day value weighted average price prior to the vesting date of the last warrants of the first tranche.
For example: getting more contracts with China, Germany, US Military, Canadian GM, and others in 30 days = PLUG in is a monsters which is just fly to Mars =STRONG BUY –BUY AS MUCH YOU CAN
For example:
Assuming, Plug Power will have received $200 million in aggregate payments from Amazon as of 12/31/2018 and the value weighted 30-day average stock price at that time calculates to $3.00, the exercise price for the second tranche warrants would amount to $2.70 (3.00 x 0.9).
Under a best case scenario, the company might even receive cash upfront for the GenCare services provided to Amazon over the course of the respective service agreements.
That said, the question-and-answer session with analysts revealed at least some additional information:
• initial revenues will be mostly tied to the company's standard GenKey offerings
• details on the announced technology collaboration still need to be worked out with Amazon, but will center around the company's new line of ProGen fuel cell engines
• firm GenKey orders of $70 million for 2017 and visibility into further deployments beyond that date similar to the company's existing agreement with Wal-Mart
• company will update on revenue and earnings guidance during its first quarter earnings conference call
• no update to unit shipment guidance at this time, but existing forecast now fully covered
• no update on the expected ratio of cash sales vs. PPA transactions for 2017
• when asked about margins: "We are pleased that this offering will allow the company to achieve its goals to reach profitability mid-next year and this will hopefully be an accelerator"
Undoubtedly, the transaction holds strong revenue potential as, according to leading supply chain and logistics consulting firm MWPVL International, Amazon currently operates more than 100 fulfilment and redistribution centers throughout the U.S. and Canada, with another 26 facilities currently planned or already under construction. With regard to the announced technology collaboration, it is obviously way too early to assign any type of future revenue contribution as the project has yet to commence.
The Motley Fool Revenue from the dea could be as high as $600 million overall.
Search
Ticker or Keyword
Go
Why Plug Power Popped 85% Today and Pulled Fuel Cell Stocks Along for the Ride
A huge deal with Amazon could bring hundreds of millions in revenue to Plug Power.
Travis Hoium (TMFFlushDraw) Apr 5, 2017 at 1:59PM
What happened
Shares of hydrogen supplier Plug Power Inc. (NASDAQ:PLUG) jumped as much as 85% on Wednesday morning after the company announced a supply agreement with retail giant Amazon (NASDAQ:AMZN). Related fuel cell suppliers Ballard Power Systems (NASDAQ:BLDP) and FuelCell Energy (NASDAQ:FCEL) popped as much as 11.1% and 10.1%, respectively.
So what
Amazon has agreed to purchase Plug Power fuel cells and hydrogen technology at select fulfillment centers. Revenue from the deal is expected to be $70 million in 2017 and Revenue from the dea could be as high as $600 million overall.
New Alert Correction re: (NASDAQ:PLUG) the Pentagon entered in negotiations with Plug Power to inquire Technology mite be used in US Military and Navy. Contract worth over 2.3 billion dollars a year
News Alert Correction PLUG worth $15.00 a share !Revenue could be as high as $600 million overall.
(NASDAQ:PLUG) Revenue from the Amazon deal is expected to be $70 million in 2017 and could be as high as $600 million overall. Strong Buy !
https://www.fool.com/investing/2017/04/05/why-plug-power-popped-85-today-and-pulled-fuel-cel.aspx
PLUG=closing at $2.80-$3.15 today = opening up $3.75- $4.90 just look at charts Good luck !WOW!
STRONG BUY--Get reach ! PLUG=All indicators pointing out PLUG=closing at $2.80-$3.15 today and opening up 6.04.2017 $3.75- $4.90 just look at charts Good luck !WOW!
GOOD NEWS read slids on adobreader http://ir.ocerainc.com/events.cfm
Good news ! Right Now you could listen a tape .you must register at www.ocerainc.com.
April 4-5, 2017 at The Westin Grand Central in New York, New York. Ocera’s presentation will take place on April 4, 2017 at 4:20 PM Eastern Time.
A live audio webcast of the presentation will be available in the "Investors" section of Ocera's website, www.ocerainc.com.
tap to listen hear http://wsw.com/webcast/needham80/ocrx/index.aspx
SYRONG BUY ARGS will get over $1 anytime
Healthcare Conference being held April 4-5, 2017 at The Westin Grand Central in New York, New York. Ocera’s presentation will take place on April 4, 2017 at 4:20 PM Eastern Time.
STRONG BUY!
Financial Officer will talk today regarding positive 3 test and exclusive sell for 7 ears OSRX will get lots of sells? Without positive results re 3 nest before 3Q shares why Financial Officer would make a publicly statements?
OCRX will fly today and tomorrow =Stung Buy
I belive aftr 3Q Ocera going to fly
NEWSWIRE) -- Ocera Therapeutics, Inc. (OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Michael Byrnes, Chief Financial Officer, will be presenting at the upcoming 16th Annual Needham Healthcare Conference being held April 4-5, 2017 at The Westin Grand Central in New York, New York. Ocera’s presentation will take place on April 4, 2017 at 4:20 PM Eastern Time.
Ocera Therapeutics Inc (OCRX) Upgraded to Buy at Zacks Investment Research
March 24th, 2017 - 0 comments - Filed Under - by Jeff Wilder
inShare
Ocera Therapeutics Inc logoZacks Investment Research upgraded shares of Ocera Therapeutics Inc (NASDAQ:OCRX) from a hold rating to a buy rating in a report issued on Thursday. The firm currently has $1.50 price objective on the biopharmaceutical company’s stock.
According to Zacks, “Ocera Therapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver diseases. Ocera Therapeutics, Inc., formerly known as Tranzyme, Inc., is based in San Diego, California. “
Several other equities research analysts have also recently weighed in on the stock. Aegis restated a buy rating and issued a $3.00 price objective on shares of Ocera Therapeutics in a research report on Saturday, March 11th. Stifel Nicolaus cut shares of Ocera Therapeutics from a buy rating to a hold rating and set a $1.00 price objective for the company. in a research report on Monday, January 30th. HC Wainwright restated a buy rating and issued a $4.00 price objective on shares of Ocera Therapeutics in a research report on Friday, March 10th. Finally, JMP Securities cut shares of Ocera Therapeutics from an outperform rating to a market perform rating in a research report on Tuesday, January 31st. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus target price of $3.90.
Analyst Recommendations for Ocera Therapeutics (NASDAQ:OCRX)
Shares of Ocera Therapeutics (NASDAQ:OCRX) traded up 4.8080% during midday trading on Thursday, hitting $1.3101. 593,486 shares of the company traded hands. The stock’s 50-day moving average is $0.89 and its 200 day moving average is $1.92. Ocera Therapeutics has a 12-month low of $0.52 and a 12-month high of $3.27. The stock’s market capitalization is $30.92 million.
A number of large investors have recently bought and sold shares of the stock. Great Point Partners LLC bought a new stake in Ocera Therapeutics during the third quarter valued at $5,184,000. Interwest Venture Management Co. bought a new stake in Ocera Therapeutics during the fourth quarter valued at $2,621,000. VHCP Management II LLC boosted its stake in Ocera Therapeutics by 14.8% in the third quarter. VHCP Management II LLC now owns 1,088,372 shares of the biopharmaceutical company’s stock valued at $2,873,000 after buying an additional 140,000 shares during the last quarter. VHCP Management LLC boosted its stake in Ocera Therapeutics by 7.5% in the third quarter. VHCP Management LLC now owns 856,550 shares of the biopharmaceutical company’s stock valued at $2,261,000 after buying an additional 60,000 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in Ocera Therapeutics by 17.9% in the fourth quarter. Renaissance Technologies LLC now owns 219,100 shares of the biopharmaceutical company’s stock valued at $460,000 after buying an additional 33,300 shares during the last quarter. Hedge funds and other institutional investors own 35.00% of the company’s stock.
About Ocera Therapeutics
Ocera Therapeutics, Inc is a clinical-stage biopharmaceutical company. The Company is focused on acute and chronic orphan liver diseases. The Company is focused on the development and commercialization of its clinical candidate, OCR-002, for the treatment of hepatic encephalopathy (HE). OCR-002 is a molecule, ornithine phenylacetate, which functions as an ammonia scavenger
http://www.dailypolitical.com/2017/03/24/ocera-therapeutics-inc-ocrx-upgraded-to-buy-at-zacks-investment-research.html
Urgent ! NEXT (OCRX) STRONG BUY HTGM up $11 in 2 days (OCRX) STRONG BUY ---wow FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars
Read more: http://www.nasdaq.com/article/fda-approves-firstever-merkel-cell-carcinoma-drug-htgm-riding-high-flxn-soars-20170324-00018#ixzz4cFrSJynJ
FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars
Read more: http://www.nasdaq.com/article/fda-approves-firstever-merkel-cell-carcinoma-drug-htgm-riding-high-flxn-soars-20170324-00018#ixzz4cFrSJynJ
Urgent ! HTGM up $11 in 2 days NEXT
(OCRX) STRONG BUY ---wow
Strong Buy Alert! = Whisper among directors OCRX that lab complete STOP-HE data successful End-of-Phase-3 and they trying to arrange meeting with FDA any day/
I believe OCRX shares will reach between $7.00- $12.00 a share before 3Q 2017. Strong Buy! I just bought 09:30:07 $ 1.16 4,000
Thank you for selling to me.
Good luck to all.
Strong Buy Alert! = Whisper among directors OCRX that lab complete STOP-HE data successful End-of-Phase-3 and they trying to arrange meeting with FDA any day/
I believe OCRX shares will reach between $7.00- $12.00 a share before 3Q 2017. Strong Buy! I just bought 09:30:07 $ 1.16 4,000
Thank you for selling to me.
Good luck to all.
BUY ALERT-SHIP-revenue up 32%
SELL ALERT-Mr. Yu IS A FRAUD NEVER BUY New Energy System-SELL SELL IT GOING BK
BUY ALERT-FREE--WILL DECLARE DIVIDEND SOON $0.12 A SHARE
STRONG BUY-FREE Book Value Per Share (mrq): $25.42 on yahoo, could be exploring a potential FREE acquisition ?
FREE -Directors Ion G. Varouxakis & Alexandros Mylonas did Fraud !
By Promised
The company believes that as a result of the reverse stock split, the company's common stock will continue to trade over $1.00 per share, which will allow the company to regain compliance with NASDAQ.
http://finance.yahoo.com/news/freeseas-transfers-stock-listing-nasdaq-130000545.html
STRONG SELL-AONEQ-NO LONGER EXISTS
What will stockholders receive as a result of the sales? Will the stock continue to trade?
• Distributions to creditors on account of their claims against A123 Systems, Inc. will be made
pursuant to a liquidating plan or other process, in either case under the supervision and with
the approval of the Bankruptcy Court.
• The stock is continuing to trade, despite the fact that we have publicly stated the common
stock is not expected to have value after the asset sales. After the sales close and the
bankruptcy process is complete, the common stock will be cancelled and we will “go dark”
by making a filing with the SEC that will officially terminate the registration of the stock.
BUY ALERT-EGLE-WILL DECLARE DIVIDEND SOON $0.12 A SHARE
STRONG BUY-EGAL-WILL DECLARE DIVIDEND SOON $0.12 A SHARE
STRONG BUY ALERT-SHIP-WILL APPROVE QUARTERLY $0.04 PER SHARE DIVIDEND
STRONG BUY ALERT-FREE-WILL APPROVE QUARTERLY $0.04 PER SHARE DIVIDEND
STRONG BUY ALERT-SHIP WILL HIT $5.99 ANY TIME WOW TIME TO BUY NOW
NEW YORK, NY--(Marketwire - Jan 8, 2013) - After struggling with a supply glut throughout much of 2012 shipping stocks have started the New Year on an impressive run as the Baltic Dry Index has begun to show signs of improvement. The Guggenheim Shipping ETF (SEA) has surged over 7 percent in the past week. Five Star Equities examines the outlook for companies in the Shipping Industry and provides equity research on Diana Shipping Inc. ( NYSE : DSX ) and Frontline Ltd. ( NYSE : FRO ).
Access to the full company reports can be found at:
http://finance.yahoo.com/news/shipping-stocks-impressive-run-start-132000936.html
Sentiment: Strong Buy